亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

VIRCHOW GROUP

Company Profile
VIRCHOW GROUP

Virchow Group, India manufactures APIs, intermediates and Biotech FDFs. Group companies hold cGMP approvals from USFDA, KFDA, EU and CEPs. APIs include Sulfamethoxazole, Sulfanilamide, Sulfasalazine, Sulfadiazine, sulfapyridine, Trimethoprim, Telmisartan, Olmesartan, Ranitidine, Cephalosporins (Oral and Sterile), Sildenafil, Itraconazole, pregabalin, Levetiracetam.  Intermediates include 7-AVCA and GCLE.

 

BIOTECH products include recombinant biosimilars, Blood Products (Albumin, Immunoglobulin), Probiotics, Oncology and cardiovascular products, Wound care products and Hyaluronic based medical devices. Virchow also undertakes contract manufacture of injectables (PFS, BFS, PEN cartridges) and topicals

more >

Year of Establishment: 1982

Total Assets(USD): 500,000 to 99,999,999

Total Number of Staff: more than 1000

Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    VIRCHOW GROUP
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service